Skip to main content
logo
Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.2400
-0.0010 (-0.41%)
Sep 18, 2026, 5:17 PM CET

Celyad Oncology Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
11829161179
Market Cap Growth
-20.00%-74.20%82.56%41.33%-85.61%-13.96%
Enterprise Value
982412-176
Last Close Price
0.240.170.710.390.513.52

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.339.17----
PS Ratio
511.56362.36158.59158.40--
PB Ratio
4.413.1257.722.562.651.82
P/TBV Ratio
4.443.1460.452.582.9610.00

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-364.31130.42114.87--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--1.770.170.060.06
Net Debt / Equity Ratio
-0.70-0.70-6.45-0.94-2.82-0.63
Net Debt / EBITDA Ratio
1.121.120.580.660.491.03
Net Debt / FCF Ratio
0.250.250.580.370.431.01
Asset Turnover
0.000.000.010.01--
Quick Ratio
1.381.381.793.341.312.34
Current Ratio
1.921.922.293.791.422.48
Return on Equity (ROE)
56.33%56.33%-170.92%-159.08%-170.72%-71.05%
Return on Assets (ROA)
-13.40%-13.40%-27.99%-33.14%-31.92%-23.32%
Return on Capital Employed (ROCE)
-61.50%-61.50%-82.90%-71.50%-273.90%-41.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
7.73%10.91%-19.74%-52.29%-358.06%-33.38%
FCF Yield
-64.23%-90.68%-19.26%-99.65%-246.08%-33.97%
Buyback Yield / Dilution
-11.68%-11.68%-61.06%-13.84%-44.80%-11.92%